These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 22037741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W, Muley T, Herb KP, Schmidt-Gayk H.
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [Abstract] [Full Text] [Related]

  • 4. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS, Lylloff L, Rønne MS, Møllehave LT, Heidemann M, Thuesen BH, Johannesen J, Schou AJ, Husby S, Wedderkopp N, Mølgaard C, Jørgensen NR.
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
    Imai T, Honda M, Maeda S, Hosoya Y, Arai T, Sumi S, Umeda H, Yano M, Koga F, Arai K, Yoshida K.
    Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
    [Abstract] [Full Text] [Related]

  • 9. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A.
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of cancer-induced bone diseases by bone metabolic marker].
    Takahashi S.
    Clin Calcium; 2006 Apr; 16(4):581- 90. PubMed ID: 16582508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy--a randomized trial.
    Rief H, Omlor G, Akbar M, Bruckner T, Rieken S, Förster R, Schlampp I, Welzel T, Bostel T, Roth HJ, Debus J.
    BMC Cancer; 2016 Mar 17; 16():231. PubMed ID: 26983672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y, Xia W, Xu L.
    PLoS One; 2014 Mar 17; 9(8):e103841. PubMed ID: 25117452
    [Abstract] [Full Text] [Related]

  • 15. Study on diagnostic value of P1NP and β-CTX in bone metastasis of patients with breast cancer and the correlation between them.
    Zuo CT, Yin DC, Fan HX, Lin M, Meng Z, Xin GW, Zhang YC, Cheng L.
    Eur Rev Med Pharmacol Sci; 2019 Jun 17; 23(12):5277-5284. PubMed ID: 31298379
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Pons F, Martínez de Osaba MJ, Echevarría M, Ballesta AM, Muñoz-Gómez J.
    Bone; 1999 Sep 17; 25(3):349-53. PubMed ID: 10495139
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in bone mass and bone turnover following tibial shaft fracture.
    Veitch SW, Findlay SC, Hamer AJ, Blumsohn A, Eastell R, Ingle BM.
    Osteoporos Int; 2006 Sep 17; 17(3):364-72. PubMed ID: 16362144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic value of some biochemical bone markers for the detection of bone metastases in prostate cancer.
    Westerhuis LW, Delaere KP.
    Eur J Clin Chem Clin Biochem; 1997 Feb 17; 35(2):89-94. PubMed ID: 9056749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.